drugset / Trial / NCT05199038

Comparison of 2 Days Versus 5 Days of Octreotide After Endoscopic Therapy in Preventing Early Esophageal Varices Rebleed : A Randomized Controlled Study

NCT05199038

Phase 4 Unknown 184 enrolled Tanta University
RandomizedParallel-groupSingle-blindTreatment

Summary

The aim of this study is to compare the efficacy of 2-days versus 5-days octreotide infusion after endoscopic therapy in preventing early esophageal varices rebleed in patients with cirrhosis.

Timeline

Start
2022-06
Primary completion
2023-06
Completion
2023-11

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Octreotide Peptide

Indications